RAB32 and colorectal carcinoma: In summary, the present data demonstrated that Rab32 in CD11c+ cells protects against the development of DSS‐induced colitis by preventing bacterial invasion and suggested that Rab32 might contribute to the pathogenesis of human IBD and IBD‐related colorectal carcinoma.